Neurexis Therapeutics
Aurora
About Neurexis Therapeutics
Neurexis Therapeutics provides stroke and cardiac arrest treatments. They offer treatments for cerebral ischemia, sickle cell anemia, congenital heart defects, vascular surgery, and pre-existing coronary disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.2M
- Funding stage: Seed
- Last round: Grant (Sep 2024)
- Website: neurexistherapeutics.com
- Phone: 720-771-6670
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/neurexis-therapeutics-131266 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.